Have a personal or library account? Click to login
Proteostasis collapse in rat’s lung tissue as one of the effects of European adder (Vipera berus subsp. berus and Vipera berus subsp. nikolskii) envenomation Cover

Proteostasis collapse in rat’s lung tissue as one of the effects of European adder (Vipera berus subsp. berus and Vipera berus subsp. nikolskii) envenomation

Open Access
|Nov 2024

References

  1. Reading CJ. Incidence, pathology, and treatment of adder (Vipera berus L.) bites in man. Emerg Med J. 1996;13:346-51.
  2. Siigur J, Siigur E. Biochemistry and toxicology of proteins and peptides purified from the venom of Vipera berus berus. Toxicon X. 2022;15:1-10.
  3. Bocian A, Urbanik M, Hus K, Lłyskowski A, Petrilla V, Andrejčáková Z, et al. Proteome and Peptidome of Vipera berus berus Venom. Molecules. 2016;21:1-13.
  4. Hønge BL, Hedegaard SK, Cederstrøm S, Nielsen H. Hospital contacts after bite by the European adder (Vipera berus). Dan Med J. 2015;62:A5022.
  5. Hamilton J, Kause J, Lamb T. Severe systemic envenomation following vipera berus bite managed with viperatab antivenom. Wilderness Environ Med. 2019;30:56-8.
  6. Gnanathasan A, Rodrigo C. Pulmonary effects and complications of snakebites. Chest. 2014;146:1403-12.
  7. Bart G, Pineau S, Biron C, Connault J, Artifoni M. Bilateral pulmonary embolism following a viper envenomation in France: A case report and review. Medicine (United States). 2016;95:1-3.
  8. Hermansen MN, Krug AH, Tjønnf jord E, Brabrand M. Envenomation by the common European adder (Vipera berus): A case series of 219 patients. Eur J Emerg Med. 2019;26:362-5
  9. Meiners S, Ballweg K. Proteostasis in pediatric pulmonary pathology. Mol Cell Pediatr. 2014;1:1-8.
  10. Shitikov V, Malenyov A, Gorelov R, Bakiev A. “Dose-response” models with mixed parameters by the example of venom toxicity estimation of the common european adder vipera berus. Principy Èkologii. 2018;2:150-60.
  11. Raksha N, Halenova T, Vovk T, Kharchenko O, Savchuk O, Samborska I, et al. Protein-peptide composition in the lungs of rats with hyperhomocysteinemia. J Biol Res-Boll Della Società Italiana Di Biologia Sperimentale. 2021;94:9858.
  12. Raksha N, Halenova T, Vovk T, Beregova T, Maievska T, Tomchuk V, et al. Isolation and partial characterization of serine proteases from jellyfish of the Antarctic region. J Appl Biol Biotechnol. 2022;11:144-50.
  13. Nykolaychyk B, Moyn V, Kyrkovskyy V. Method for determining of the peptide pool molecular. Lab Case. 1991;10:13-8.
  14. Amiri A, Nikitina N, Stepanova L, Beregova T. Potential impact of cerium dioxide nanoparticles (nanoceria) on the concentration of c-reactive protein and middle-mass molecules after wound treatment in rats. ScienceRise: Biol Sci. 2019;1:14-9.
  15. Denefil O. The rates of middle molecules in the blood in rats with different motor activity in alcoholic and non alcoholic exerimental hepatosis. J Edu Health Sport. 2021;11:385-95.
  16. Herrera C, Escalante T, Voisin MB, Rucavado A, Morazán D, Macêdo JKA, et al. Tissue localization and extracellular matrix degradation by PI, PII and PIII snake venom metalloproteinases: Clues on the mechanisms of venom-induced hemorrhage. PLoS Negl Trop Dis. 2015;9:1-20.
  17. Gutiérrez JM, Rucavado A, Escalante T, Herrera C, Fernández J, Lomonte B, et al. Unresolved issues in the understanding of the pathogenesis of local tissue damage induced by snake venoms. Toxicon. 2018;148:123-31.
  18. Zinenko O, Tovstukha I, Korniyenko Y. PLA2 inhibitor varespladib as an alternative to the antivenom treatment for bites from nikolsky’s viper Vipera berus nikolskii. Toxins (Basel). 2020;12:1-7.
  19. María Gutiérrez J, Rucavado A. Snake venom metalloproteinases: Their role in the pathogenesis of local tissue damage. Biochimie. 2000;82:841-50.
  20. Burgstaller G, Oehrle B, Gerckens M, White ES, Schiller HB, Eickelberg O. The instructive extracellular matrix of the lung: Basic composition and alterations in chronic lung disease. Eur Resp J. 2017;50:1601805.
  21. Bouchecareilh M, Balch WE. Proteostasis: A new therapeutic paradigm for pulmonary disease. Proc Am Thorac Soc. 2011;8:189-95.
  22. Twining SS, Simmons WH. Regulation of proteolytic activity in tissues. Crit Rev Biochem Mol Biol. 1994;29:315-83
  23. Chakrabarti S, Patel KD. Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res. 2005;31:599-621.
  24. Warner RL, Beltran L, Younkin EM, Lewis CS, Weiss SJ, Varani J, et al. Role of Stromelysin 1 and Gelatinase B in experimental acute lung injury. Am J Respir Cell Mol Biol. 2001;24:537-44.
  25. Mykolenko AZ. Changes of concentration of middle mass molecules in blood serum in the early days of isolated orthopedic trauma complicated by blood loss. Deutscher Wissenschaftsherold. 2016;2:16-8.
  26. Schulte I, Tammen H, Selle H, Schulz-Knappe P. Peptides in body fluids and tissues as markers of disease. Expert Rev Mol Diagn. 2005;5:145-57.
  27. Kisling A, Lust RM, Katwa LC. What is the role of peptide fragments of collagen I and IV in health and disease? Life Sci. 2019;228:30-4.
DOI: https://doi.org/10.2478/cipms-2024-0032 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 195 - 199
Submitted on: Mar 4, 2023
|
Accepted on: Sep 28, 2023
|
Published on: Nov 28, 2024
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Serhii Shchypanskyi, Oleksandr Maievskyi, Vladyslav Lasavutz, Liudmyla Sokurenko, Nataliia Raksha, Tetiana Halenova, Tetiana Vovk, Olexii Savchuk, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.